Browse studies

Find your next paid study

3,083 recruiting studies matching your filters

Feasibility of Home-based Immersive Neurofeedback Self-regulation Training (INSeRT) for Youth With Migraine

The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with mig…

MigraineHeadache Disorders, Primary

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Mercy Hospital Kansas CityNCT07454798

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study of RBS2418 Plus Best Supportive Care (BSC) in Subjects With Advanced, Metastatic, and Progressive Colorectal Cancer

RBS2418 is a specific immune modulator that works through the inhibition of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and is designed to lead …

Metastatic Colorectal CancerAdvanced Colorectal Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Riboscience, LLC.NCT06824064

Observational

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

The goal of this clinical trial is to learn if a tailored intervention can help make it easier for adolescents and young adults with cancer to take their medic…

CancerMedication Adherence

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT07223463

Phase 1

A First-in-human, Open-label, Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Activity of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

The study is being conducted to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of 3HP-2827 in the treatment of unresectabl…

Solid Tumors With FGFR2 Alterations, Adult

Estimated

~$150 – $4,200

Actual pay is set by the research site.

3H (Suzhou) Pharmaceuticals Co., Ltd.NCT06287918

Phase 3

A Clinically Integrated Randomized Clinical Trial (RCT) of Modifications to Radical Cystectomy and Postoperative Care

The purpose of this study is to look at two standard surgical techniques used during a radical cystectomy and see whether they influence outcomes such as lengt…

Bladder Cancer

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT06703476

Observational

SURG-236: Prehabilitation in High-risk Oncologic Surgery: A Prospective Cohort Study

The goal of this clinical study is to learn whether a prehabilitation program can improve recovery after major abdominal surgery in adults with cancer who are …

Pancreatic CancerColo-rectal CancerGastric Cancer+4 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Fox Chase Cancer CenterNCT07638410

Phase 2

SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW/ULTRA LOW MetaStatic Breast Cancer

The purpose of this research study is to see if the medication sacituzumab govitecan (SG) is effective at the currently approved dose and schedule in people wh…

Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+2 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Reshma L. Mahtani, D.O.NCT06263543

Phase 1

A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGridTM Electroporation Delivery System to Patients With HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia

The primary goal of this phase I open label study is to determine the safety and tolerability of pNGVL4aCRTE6E7L2 DNA vaccine, as administered by intramuscular…

Human Papillomavirus Type 16Cervical Intraepithelial Neoplasia Grade IICervical Intraepithelial Neoplasia, Grade III

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04131413

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Sonoma Biotherapeutics, Inc.NCT07123038

Phase 4

A Randomized Study of Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for tre…

Concussion Post SyndromeHead Trauma Injury

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Montefiore Medical CenterNCT07634393

Phase 1

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

This research study is an open-label Phase 1 Exploratory/Pilot clinical trial to measure the effects of the incretin mimetic, tirzepatide, on tissue, urine, bl…

Colorectal Cancer PreventionColorectal Adenoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Massachusetts General HospitalNCT07095517

The Ohio State University Dermatology Biorepository

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Hidradenitis Suppurativa

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State UniversityNCT03146676